ALXO
Price
$15.74
Change
-$0.34 (-2.11%)
Updated
Apr 18, 6:59 PM EST
19 days until earnings call
BCYC
Price
$24.49
Change
+$2.67 (+12.24%)
Updated
Apr 18, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare trend and price ALXO vs BCYC

Header iconALXO vs BCYC Comparison
Open Charts ALXO vs BCYCBanner chart's image
ALX Oncology Holdings
Price$15.74
Change-$0.34 (-2.11%)
Volume$401.47K
CapitalizationN/A
Bicycle Therapeutics
Price$24.49
Change+$2.67 (+12.24%)
Volume$320.52K
CapitalizationN/A
View a ticker or compare two or three
ALXO vs BCYC Comparison Chart

Loading...

ALXODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALXO vs. BCYC commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and BCYC is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (ALXO: $15.74 vs. BCYC: $24.49)
Brand notoriety: ALXO and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALXO: 129% vs. BCYC: 165%
Market capitalization -- ALXO: $789.39M vs. BCYC: $930.58M
ALXO [@Biotechnology] is valued at $789.39M. BCYC’s [@Biotechnology] market capitalization is $930.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileBCYC’s FA Score has 0 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • BCYC’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 4 TA indicator(s) are bullish while BCYC’s TA Score has 7 bullish TA indicator(s).

  • ALXO’s TA Score: 4 bullish, 5 bearish.
  • BCYC’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than ALXO.

Price Growth

ALXO (@Biotechnology) experienced а +17.64% price change this week, while BCYC (@Biotechnology) price change was +8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.71%. For the same industry, the average monthly price growth was -2.42%, and the average quarterly price growth was +1224.03%.

Reported Earning Dates

ALXO is expected to report earnings on Aug 07, 2024.

BCYC is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-7.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALXO with price predictions.
OPEN
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCYC($931M) has a higher market cap than ALXO($789M). BCYC YTD gains are higher at: 20.686 vs. ALXO (5.709).
ALXOBCYCALXO / BCYC
Capitalization789M931M85%
EBITDAN/AN/A-
Gain YTD5.70920.68628%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALXOBCYC
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 23 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALXODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRXRX12.040.01
+0.08%
MFS Blended Research Intl Eq R1
FOSFX62.06-0.14
-0.23%
Fidelity Overseas
CLTCX14.43-0.06
-0.41%
Catalyst/Lyons Tactical Allocation C
DESGX21.03-0.11
-0.52%
DWS ESG Core Equity Institutional
OCLGX12.73-0.14
-1.09%
Optimum Large Cap Growth C

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
-2.11%
MDGL - ALXO
56%
Loosely correlated
-2.66%
AXON - ALXO
45%
Loosely correlated
-0.74%
AMRN - ALXO
43%
Loosely correlated
-4.94%
ALNY - ALXO
39%
Loosely correlated
-0.11%
AKRO - ALXO
39%
Loosely correlated
-5.05%
More

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.50%
PHIO - BCYC
41%
Loosely correlated
-0.79%
MLTX - BCYC
39%
Loosely correlated
+0.02%
ORMP - BCYC
35%
Loosely correlated
-2.92%
SAGE - BCYC
34%
Loosely correlated
-19.58%
AXON - BCYC
34%
Loosely correlated
-0.16%
More